CN101721600A - Medicine for treating neurasthenia - Google Patents

Medicine for treating neurasthenia Download PDF

Info

Publication number
CN101721600A
CN101721600A CN200810194730A CN200810194730A CN101721600A CN 101721600 A CN101721600 A CN 101721600A CN 200810194730 A CN200810194730 A CN 200810194730A CN 200810194730 A CN200810194730 A CN 200810194730A CN 101721600 A CN101721600 A CN 101721600A
Authority
CN
China
Prior art keywords
medicine
raw materials
rhizoma anemarrhenae
poria
weight percent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810194730A
Other languages
Chinese (zh)
Inventor
胡彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200810194730A priority Critical patent/CN101721600A/en
Publication of CN101721600A publication Critical patent/CN101721600A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicine for treating neurasthenia, which is prepared by taking rehmannia root, jujube kernel, schisandra fruit, rhizoma anemarrhenae, tuckahoe and senega as raw materials. The medicine has good use effect and definite curative effect, and the effective rate is as high as more than 75%.

Description

Treat neurasthenic medicine
Technical field:
The present invention relates to the neurasthenic medicine of a kind of treatment.
Background technology:
The medicine of the neurasthenic medicine of existing treatment generally adopts Western medicine, and to part patient unsatisfactory curative effect, what have has certain side reaction.
Summary of the invention:
The object of the present invention is to provide the neurasthenic medicine of the good treatment of a kind of therapeutic effect.
Technical solution of the present invention is:
The neurasthenic medicine of a kind of treatment is characterized in that: made by following raw materials by weight percent:
The Radix Rehmanniae 25~35%
Semen Ziziphi Spinosae 25~35%
Fructus Schisandrae Chinensis 10~25%
The Rhizoma Anemarrhenae 10~25%.
Poria 10~20%
Radix Polygalae 10~20%.
The neurasthenic medicine of described treatment, make by following raw materials by weight percent:
The Radix Rehmanniae 30%
Semen Ziziphi Spinosae 30%
Fructus Schisandrae Chinensis 10%
The Rhizoma Anemarrhenae 10%.
Poria 10%
Radix Polygalae 10%.
Result of use of the present invention is good, determined curative effect, and effective percentage is up to more than 75%.
The invention will be further described below in conjunction with embodiment.
The specific embodiment:
Embodiment 1:
The neurasthenic medicine of a kind of treatment, make by following raw materials by weight percent:
The Radix Rehmanniae 30%
Semen Ziziphi Spinosae 30%
Fructus Schisandrae Chinensis 10%
The Rhizoma Anemarrhenae 10%.
Poria 10%
Radix Polygalae 10%.
During making, according to the preparation method preparation of conventional granulates preparation or tablet.
Embodiment 2:
The neurasthenic medicine of a kind of treatment, make by following raw materials by weight percent:
The Radix Rehmanniae 25%
Semen Ziziphi Spinosae 25%
Fructus Schisandrae Chinensis 15%
The Rhizoma Anemarrhenae 15%.
Poria 10%
Radix Polygalae 10%.
During making, according to the preparation method preparation of conventional granulates preparation or tablet.

Claims (2)

1. treat neurasthenic medicine for one kind, it is characterized in that: make by following raw materials by weight percent:
The Radix Rehmanniae 25~35%
Semen Ziziphi Spinosae 25~35%
Fructus Schisandrae Chinensis 10~25%
The Rhizoma Anemarrhenae 10~25%.
Poria 10~20%
Radix Polygalae 10~20%.
2. the neurasthenic medicine of treatment according to claim 1 is characterized in that: made by following raw materials by weight percent:
The Radix Rehmanniae 30%
Semen Ziziphi Spinosae 30%
Fructus Schisandrae Chinensis 10%
The Rhizoma Anemarrhenae 10%.
Poria 10%
Radix Polygalae 10%.
CN200810194730A 2008-10-18 2008-10-18 Medicine for treating neurasthenia Pending CN101721600A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810194730A CN101721600A (en) 2008-10-18 2008-10-18 Medicine for treating neurasthenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810194730A CN101721600A (en) 2008-10-18 2008-10-18 Medicine for treating neurasthenia

Publications (1)

Publication Number Publication Date
CN101721600A true CN101721600A (en) 2010-06-09

Family

ID=42443550

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810194730A Pending CN101721600A (en) 2008-10-18 2008-10-18 Medicine for treating neurasthenia

Country Status (1)

Country Link
CN (1) CN101721600A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716313A (en) * 2012-07-05 2012-10-10 河北工程大学 Anti-dairy cow transport stress pharmaceutical composition
CN104623352A (en) * 2013-11-08 2015-05-20 成都百草和济科技有限公司 Medicine composition for improving sleep
CN106177823A (en) * 2015-05-06 2016-12-07 刘宽明 A kind of controlling drinks cold, the formula of vomiting and diarrhoea summer
CN106177167A (en) * 2015-05-06 2016-12-07 刘宽明 A kind of formula controlling coronary heart disease
CN106177398A (en) * 2015-05-05 2016-12-07 刘宽明 A kind of formula controlling chronic nervous exhaustion

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716313A (en) * 2012-07-05 2012-10-10 河北工程大学 Anti-dairy cow transport stress pharmaceutical composition
CN104623352A (en) * 2013-11-08 2015-05-20 成都百草和济科技有限公司 Medicine composition for improving sleep
CN104623352B (en) * 2013-11-08 2018-01-05 成都百草和济科技有限公司 A kind of pharmaceutical composition for improving sleep
CN106177398A (en) * 2015-05-05 2016-12-07 刘宽明 A kind of formula controlling chronic nervous exhaustion
CN106177823A (en) * 2015-05-06 2016-12-07 刘宽明 A kind of controlling drinks cold, the formula of vomiting and diarrhoea summer
CN106177167A (en) * 2015-05-06 2016-12-07 刘宽明 A kind of formula controlling coronary heart disease

Similar Documents

Publication Publication Date Title
CN101721600A (en) Medicine for treating neurasthenia
CN101721632A (en) Eupeptic medicine
CN101406631B (en) Medicament for treating hyperkinetic symptom of children
CN101721581A (en) Medicine for treating ascarid of biliary tract
CN102462793A (en) Medicine for treating infantile diarrhea
CN102018818A (en) Medicine for treating myasthenia gravis
CN103784910A (en) Foot bath medicament for treating hypertension
CN101721650A (en) Medicine for treating infantile diarrhea
CN101773639A (en) Drug for treatment of Parkinson disease
CN101721541A (en) Medicine for treating erysipelas
CN102018816A (en) Traditional Chinese medicine for treating anaphylactoid purpura
CN101721649A (en) Medicine for relieving diarrhea
CN101766772A (en) Medicament for treating acute gastritis
CN101773617A (en) Drug for treatment of asthmatic bronchitis
CN101721482A (en) medicine for treating pharyngitis
CN101721490A (en) Medicine for treating bacillary dysentery
CN101721473A (en) Medicine for preventing asthma
CN101766798A (en) Medicament for treating chronic superficial gastritis
CN101773576A (en) Drug for treatment of hypertension
CN101721536A (en) Medicine for treating papular urticaria
CN101773640A (en) Drug for treatment of myocarditis
CN101919958A (en) Medicine for treating neurasthenia
CN102018901A (en) Traditional Chinese medicine for treating neurosis
CN101721526A (en) medicine for treating keratitis
CN109303813A (en) A kind of Chinese medicine composition for treating fistula disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100609